Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials-Reference-Cited by-同舟云学术

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Published:2010-05 Issue:9727 Volume:375 Page:1695-1703
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lees Kennedy R,Bluhmki Erich,von Kummer Rüdiger,Brott Thomas G,Toni Danilo,Grotta James C,Albers Gregory W,Kaste Markku,Marler John R,Hamilton Scott A,Tilley Barbara C,Davis Stephen M,Donnan Geoffrey A,Hacke Werner

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Tissue plasminogen activator for acute ischemic stroke;N Engl J Med,1995

2. Alteplase compared with placebo within 3 to 4·5 hours for acute ischemic stroke;Hacke;N Engl J Med,2008

3. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS);Hacke;JAMA,1995

4. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II);Hacke;Lancet,1998

5. The rt-PA (alteplase) 0- to 6-hour acute stroke trial, part A (A0267g): results of a double-blind, placebo-controlled, multicenter study;Clark;Stroke,2000

Cited by 1827 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial;International Journal of Stroke;2024-09-11

2. Complications of Carotid Interventions for Symptomatic Lesions after Systemic Thrombolysis;Annals of Vascular Surgery;2024-09

3. Patients with acute intracerebral hemorrhage and severe symptoms are highly sensitive to prehospital delay. A subgroup analysis from the RESIST and TRIAGE-STROKE trials;Frontiers in Stroke;2024-08-21

4. Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia;Cytokine;2024-08

5. The Future of Fibrinolysis Agents;Biochemistry;2024-07-22